Remus Pharmaceuticals
₹7,203.85
-228.8 (-3.08%)
10 May, 2024 01:15 BSE:
NSE: REMUSISIN: INE0O5T01011
Start SIP in Remus Pharmaceuticals
Start SIPRemus Pharmaceuticals Performance
Day Range
- Low 7,155
- High 7,550
52 Week Range
- Low 1,711
- High 8,747
- Open Price7,550
- Previous Close7,433
- Volume1675
Remus Pharmaceuticals Financials
Indicator | Mar 2023 |
---|---|
Total Revenue Annual Cr | 47 |
Operating Expenses Annual Cr | 34 |
Operating Profit Annual in Cr | 11 |
Depreciation Cr | 0 |
Interest Annual Cr | 0 |
Tax Annual Cr | 3 |
Net Profit Annual Cr | 9 |
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹7,203.85
-228.8 (-3.08%)
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹7,110.55
- 50 Day
- ₹6,679.84
- 100 Day
- ₹6,332.14
- 200 Day
- ₹5,528.53
- 20 Day
- ₹6,945.24
- 50 Day
- ₹6,351.34
- 100 Day
- ₹6,547.21
- 200 Day
- ₹5,689.14
Remus Pharmaceuticals Resistance and Support
PIVOT
₹7,302.95
Resistance | |
---|---|
First Resistance | 7,450.90 |
Second Resistance | 7,697.95 |
Third Resistance | 7,845.90 |
RSI | 53.29 |
MFI | 74.32 |
MACD Single Line | 364.80 |
MACD | 357.85 |
Support | |
---|---|
First Resistance | 7,055.90 |
Second Resistance | 6,907.95 |
Third Resistance | 6,660.90 |
Remus Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 1,675 | 107,502 | 64.18 |
Week | 3,030 | 215,009 | 70.96 |
1 Month | 5,162 | 306,046 | 59.29 |
6 Month | 2,580 | 173,158 | 67.11 |
Remus Pharmaceuticals Result Highlights
Remus Pharmaceuticals Synopsis
NSE-Medical-Whlsle Drg/Suppl
Remus Pharmaceutic belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.03 Cr. and Equity Capital is Rs. 1.09 Cr. for the Year ended 31/03/2023. Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536.Market Cap | 1,055 |
Sales | 45 |
Shares in Float | 0.04 |
No of funds | 3 |
Yield | 0.03 |
Book Value | 40.6 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | 37 |
Alpha | 0.55 |
Beta | 1.5 |
Remus Pharmaceuticals
Owner Name | Mar-24 | Sep-23 |
---|---|---|
Promoters | 70.6% | 69.61% |
Foreign Portfolio Investors | 3.25% | 2.38% |
Financial Institutions/ Banks | ||
Individual Investors | 20.54% | 21.15% |
Others | 5.61% | 6.86% |
Remus Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Swapnil Jatinbhai Shah | Chairman & Wholetime Director |
Mr. Arpit Deepakkumar Shah | Managing Director |
Mrs. Anar Swapnil Shah | Whole Time Director |
Ms. Roma Vinodbhai Shah | Whole Time Director |
Mr. Balwant Purohit | Independent Director |
Mrs. Sanjana Sanjeev Shah | Independent Director |
Mr. Vishrut Chandramauli Pathak | Independent Director |
Remus Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Remus Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-04-23 | Bonus issue & Interim Dividend | |
2024-04-22 | Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2024-05-02 | INTERIM | Rs.0.00 2nd interim dividend of Rs. 4.00/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24. |
2023-10-28 | INTERIM | Rs.0.00 Interim Dividend of Rs. 2 per equity share. |
Remus Pharmaceuticals FAQs
What is Share Price of Remus Pharmaceuticals ?
Remus Pharmaceuticals share price is ₹7,203 As on 10 May, 2024 | 01:01
What is the Market Cap of Remus Pharmaceuticals ?
The Market Cap of Remus Pharmaceuticals is ₹1061.1 Cr As on 10 May, 2024 | 01:01
What is the P/E ratio of Remus Pharmaceuticals ?
The P/E ratio of Remus Pharmaceuticals is As on 10 May, 2024 | 01:01
What is the PB ratio of Remus Pharmaceuticals ?
The PB ratio of Remus Pharmaceuticals is 55.5 As on 10 May, 2024 | 01:01